葡萄糖皮质体受体信号调解对矩阵度诱导的休眠大脑转移性乳腺癌的治疗阻力
Sofia N Luna1, Venu Yakati1, Lalita A Shevde2
1Department of Chemical and Biological Engineering, The University of Alabama, Tuscaloosa, Alabama 35487, United States.
ACS biomaterials science & engineering
|September 5, 2025
概括
休眠的大脑转移性乳腺癌 (BMBC) 球体由于母体刚性而抵抗化疗. 葡萄糖皮质体受体 (GR) 信号驱动这种抵抗,可以通过抑制SGK1来克服.
科学领域:
- 癌症学
- 生物材料科学
- 细胞生物学
背景情况:
- 大脑转移性乳腺癌 (BMBC) 往往进入休眠状态,导致抗治疗.
- 在休眠的BMBC中存在耐药性的机制尚不清楚.
- 瘤微环境,特别是基质刚性,影响癌细胞休眠和行为.
研究的目的:
- 研究基因刚性诱导的休眠和BMBC球体的耐药性之间的联系.
- 阐明休眠的BMBC中介于治疗阻力的分子途径.
- 探索潜在的治疗策略, 针对与休眠相关的耐药性.
主要方法:
- 在不同硬度 (软度~0.4 kPa,硬度~4.5 kPa) 的氨酸 (HA) 水凝上培养BMBC球体,以诱导休眠或增殖.
- 评估对帕克利塔克塞尔 (PTX) 和拉帕提尼布 (LAP) 治疗的球体反应.
- 分析葡萄糖皮质体受体 (GR) 信号通路,包括SGK-1,RANBP1,β-catenin和GSK-3β在药物耐药性中介作用.
主要成果:
- 在软HA水凝 (休眠状态) 上的BMBC球体对PTX和LAP表现出耐药性.
- 硬的HA水凝上的BMBC球体 (增殖状态) 对PTX和LAP治疗敏感.
- 在休眠的BMBC中,药物耐药性通过SGK-1/ RANBP1 (三阴性) 或β-catenin/ GSK-3β (HER2+) 的GR信号传递.
- 抑制SGK1成功地逆转了药物耐药性,并恢复了治疗敏感性.
结论:
- 在BMBC中诱导休眠和随后的药物耐药性方面,矩阵刚性起着至关重要的作用.
- 葡萄糖皮质体受体 (GR) 信号传递是BMBC中休眠相关治疗耐药性的关键媒介.
- 针对GR信号,特别是SGK1,是一个有前途的治疗策略,以克服休眠的BMBC药物耐药性.
相关概念视频
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
692
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
692
Cushing Syndrome II: Pathophysiology
24
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24


